Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 35Neoplasm Metastasis 32Myelodysplastic Syndromes 18Lung Neoplasms 16Colorectal Neoplasms 14Pancreatic Neoplasms 12Breast Neoplasms 12Multiple Myeloma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Carcinoma, Non-Small-Cell Lung 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Melanoma 10Triple Negative Breast Neoplasms 9Prostatic Neoplasms 9Glioblastoma 9Lymphoma, Follicular 8Carcinoma, Renal Cell 8Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, B-Cell 7Astrocytoma 7Ovarian Neoplasms 6Glioma 6Burkitt Lymphoma 6Squamous Cell Carcinoma of Head and Neck 5Lymphoma, T-Cell 5Lymphoma, Mantle-Cell 5Leukemia, Biphenotypic, Acute 5Hematologic Neoplasms 5Stomach Neoplasms 4

Interventions

Cyclophosphamide 12fludarabine 10fludarabine phosphate 7Radiotherapy 6Mycophenolic Acid 6Whole-Body Irradiation 5Sirolimus 5Filgrastim 5Tacrolimus 4Melphalan 4Busulfan 4Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Cyclosporine 3Thiotepa 2Stem Cell Transplantation 2Specimen Handling 2Rituximab 2Methotrexate 2Mesna 2Granulocyte Colony-Stimulating Factor 2Etoposide 2venetoclax 1siplizumab 1rasburicase 1prostaglandin D2 receptor 1milatuzumab 1itacitinib 1eritoran 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Graft vs Host Disease × Specimen Handling × Clear all
NCT07611370 2026-05-28

Evaluating the Effects of Propionate and Butyrate Supplementation on the Intestinal Health of Healthy Volunteers

City of Hope Medical Center

Phase 1 Not yet recruiting
12 enrolled

Graft vs Host Disease

NCT06996119 2026-05-11

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

City of Hope Medical Center

Phase 1 Recruiting
15 enrolled
MyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡